59 results
8-K
EX-99.1
PASG
Passage Bio Inc
7 Aug 23
Passage Bio Reports Second Quarter 2023 Financial Results and Provides Recent Business Highlights
7:15am
with current and potential delays, work stoppages, or supply chain disruptions caused by the coronavirus pandemic; and the other risks
8-K
EX-99.2
PASG
Passage Bio Inc
7 Aug 23
Passage Bio Reports Second Quarter 2023 Financial Results and Provides Recent Business Highlights
7:15am
disruptions caused by the coronavirus pandemic; and the other risks and uncertainties that are described in the Risk Factors section in documents
8-K
EX-99.3
PASG
Passage Bio Inc
7 Aug 23
Passage Bio Reports Second Quarter 2023 Financial Results and Provides Recent Business Highlights
7:15am
, work stoppages, or supply chain disruptions caused by the coronavirus pandemic; and the other risks and uncertainties that are described in the Risk
8-K
EX-99.2
8sd1s nulj8j
14 Dec 22
Passage Bio Announces Positive Interim Clinical Data from First Six Patients with GM1 Gangliosidosis in Imagine-1 Study
7:00am
8-K
EX-99.1
r8ao6bxs8q25b7izye
14 Dec 22
Passage Bio Announces Positive Interim Clinical Data from First Six Patients with GM1 Gangliosidosis in Imagine-1 Study
7:00am
8-K
EX-99.1
6lp3v8cbc4ulo24fq
10 Nov 22
Passage Bio Reports Third Quarter 2022 Financial Results And Provides Business Updates
7:03am
8-K
EX-99.2
5oyq97wdjcusgjeqb
10 Nov 22
Passage Bio Reports Third Quarter 2022 Financial Results And Provides Business Updates
7:03am
8-K
EX-99.2
326vsvre1ixj7e2rl16q
4 Aug 22
Passage Bio Reports Second Quarter 2022 Financial Results and Provides Recent Business Highlights
7:20am
8-K
EX-99.1
tl4yrvgl60zag
4 Aug 22
Passage Bio Reports Second Quarter 2022 Financial Results and Provides Recent Business Highlights
7:20am
8-K
EX-99.1
pmj9zilw710 oerpcg
18 May 22
Passage Bio Presents New Interim Clinical and Biomarker
7:16am
8-K
EX-99.1
cjy amcyfrs
16 May 22
Passage Bio Reports First Quarter 2022 Financial Results and Provides Recent Business Highlights
7:15am
8-K
EX-99.2
5ss0i0 hs4wsv3
16 May 22
Passage Bio Reports First Quarter 2022 Financial Results and Provides Recent Business Highlights
7:15am
POS AM
hi9crxxo9kyitdragqyr
3 Mar 22
Prospectus update (post-effective amendment)
8:29am